तुलना करने के लिए मीट्रिक्स | MXCT | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधMXCTपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −3.6x | −6.1x | −0.4x | |
PEG अनुपात | −0.48 | 0.01 | 0.00 | |
क़ीमत/बुक | 0.8x | 1.1x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 4.4x | 2.6x | 3.0x | |
अपसाइड (विश्लेषक लक्ष्य) | 238.3% | 11.7% | 51.5% | |
उचित मूल्य अपसाइड | अनलॉक करें | 29.2% | 8.8% | अनलॉक करें |
MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes cell therapeutics in the United States and internationally. The company's products consists of ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. It also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. The company licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.